Disease States: Psychosis in Alzheimer’s disease

Psychosis in Alzheimer’s disease

AAIC 2023

Design of ADEPT-2, a Phase 3, Parallel-Group Study to Evaluate KarXT (Xanomeline-Trospium)
as a Treatment for Psychosis Associated With Alzheimer’s Disease

CTAD 2022

Evaluating KarXT (Xanomeline–Trospium) as a Treatment for Psychosis Associated With Alzheimer’s Disease Dementia: Design of the Phase 3, ADEPT-1, Relapse Prevention Study

ASCP 2019

Xanomeline Plus Trospium: A Novel Strategy to Enhance Pro-Muscarinic Efficacy and Mitigate Peripheral Side Effects